ArticleBMJ open2025

Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial).

Conrad Rauber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.